Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ryan
A Menter

Showing results (971-980 of 1,066) with videos related to

Pageof 107
Sort By:
Cancer Chemotherapy and Pharmacology|September 4, 2014
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasmsWilliam D Figg, Manish Monga, Donna Headlee, et al.
Human Brain Mapping|November 29, 2017
Integration of routine QA data into mega-analysis may improve quality and sensitivity of multisite diffusion tensor imaging studiesPeter Kochunov, Erin W Dickie, Joseph D Viviano, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Journal of Gastroenterology and Hepatology|February 18, 2024
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapyN M Batt, B Rodrigues, S Bloom, et al.
Human Brain Mapping|February 3, 2022
The additive impact of cardio-metabolic disorders and psychiatric illnesses on accelerated brain agingMeghann C Ryan, L Elliot Hong, Kathryn S Hatch, et al.
Scientific Reports|January 21, 2018
Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian gliomaNina P Connolly, Amol C Shetty, Jesse A Stokum, et al.
European Urology|March 12, 2014
ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinomaSamira A Brooks, A Rose Brannon, Joel S Parker, et al.
Cancer Cell|June 16, 2012
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaWenjin Liu, Kimberly B Monahan, Adam D Pfefferle, et al.
The Journal of Clinical Investigation|April 9, 2013
HIF1α and HIF2α independently activate SRC to promote melanoma metastasesSara C Hanna, Bhavani Krishnan, Sean T Bailey, et al.
Neuro-Oncology|June 13, 2017
MerTK as a therapeutic target in glioblastomaJing Wu, Lauren N Frady, Ryan E Bash, et al.
Pageof 107

Showing results (971-980 of 1,066) with videos related to

Sort By:
Pageof 107
Cancer Chemotherapy and Pharmacology|September 4, 2014
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasmsWilliam D Figg, Manish Monga, Donna Headlee, et al.
Human Brain Mapping|November 29, 2017
Integration of routine QA data into mega-analysis may improve quality and sensitivity of multisite diffusion tensor imaging studiesPeter Kochunov, Erin W Dickie, Joseph D Viviano, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Journal of Gastroenterology and Hepatology|February 18, 2024
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapyN M Batt, B Rodrigues, S Bloom, et al.
Human Brain Mapping|February 3, 2022
The additive impact of cardio-metabolic disorders and psychiatric illnesses on accelerated brain agingMeghann C Ryan, L Elliot Hong, Kathryn S Hatch, et al.
Scientific Reports|January 21, 2018
Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian gliomaNina P Connolly, Amol C Shetty, Jesse A Stokum, et al.
European Urology|March 12, 2014
ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinomaSamira A Brooks, A Rose Brannon, Joel S Parker, et al.
Cancer Cell|June 16, 2012
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaWenjin Liu, Kimberly B Monahan, Adam D Pfefferle, et al.
The Journal of Clinical Investigation|April 9, 2013
HIF1α and HIF2α independently activate SRC to promote melanoma metastasesSara C Hanna, Bhavani Krishnan, Sean T Bailey, et al.
Neuro-Oncology|June 13, 2017
MerTK as a therapeutic target in glioblastomaJing Wu, Lauren N Frady, Ryan E Bash, et al.
Pageof 107